The New Zealand Antimicrobial Resistance Action Plan will be implemented over 5 years, starting in 2017. Some activities will be ongoing, while some will be prioritised in year 1 or in later years.
Implementation of the five-year New Zealand Antimicrobial Resistance Action Plan started in 2017. Some activities will be ongoing, some have been prioritised for year 1 and others for later years.
The Ministry for Primary Industries and Ministry of Health are jointly governing the plan. Implementing the activities will involve a variety of partners from across the human health, animal health and agriculture sectors.
The plan includes 18 priority action areas with specific activities to be implemented over five years. Ongoing and year 1 activities are listed below. Activities may be amended in later years to ensure the success of the plan.
Priority action areas
- Strengthen consumer awareness to improve understanding of antimicrobial resistance and the importance of using antibiotics appropriately.
- Strengthen communication and education initiatives on antimicrobial resistance and stewardship for all prescribers, and those working in the human health, animal health and agricultural sectors.
- Establish a coordinated national surveillance programme of antimicrobial resistance and antimicrobial use in humans, animals and agriculture.
- Develop lists of priority organisms, key resistance genes and antimicrobials for national reporting.
- Implement a national minimum standard for laboratory testing and reporting of antimicrobial susceptibility.
- Support national priorities for research on antimicrobial resistance, antimicrobial consumption and stewardship in human health, animal health and agriculture.
- Develop and update national guidelines and standards for IPC to achieve a nationally consistent approach, and enhance accreditation and quality assurance programmes so that more practitioners follow best-practice IPC measures across human health, animal health and agriculture.
- Promote a cohesive and sustainable ‘one team’ approach to IPC functions in all human health care facilities.
- Encourage continued immunisation to prevent infections.
- Promote prevention and control of zoonotic infections.
- Encourage alternative approaches to reduce infection and the need for antimicrobial use in animals.
- Develop a national programme or standard for AMS in all sectors of human health, including resources and/or targets for use in all sectors.
- Develop a national programme or standard for AMS in animal health.
- Establish a programme of regularly monitoring the controls on antimicrobial veterinary medicines.
- Review the controls (conditions of registration), labelling and advertising of antimicrobial-based trade name products to ensure they are fit for purpose.
- Establish a sustainable national governance structure to coordinate all efforts to minimise antimicrobial resistance.
- Ensure that there is sustainable investment in initiatives to minimise the impacts of antimicrobial resistance. This includes ongoing investment in surveillance, communication, stewardship and infection prevention and control.
- Establish the necessary national and international links and collaborations to implement the AMR Action Plan effectively.